Medical Care
Global Carbapenem-Based Antibiotics Market Research Report 2025
- Apr 07, 25
- ID: 167669
- Pages: 75
- Figures: 78
- Views: 32
The global market for Carbapenem-Based Antibiotics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Carbapenem-Based Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Carbapenem-Based Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Carbapenem-Based Antibiotics in Retail Pharmacies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Carbapenem-Based Antibiotics include ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, Gland Pharma Limited, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Savior Lifetec, Pfizer Inc., Spero Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Carbapenem-Based Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbapenem-Based Antibiotics.
The Carbapenem-Based Antibiotics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Carbapenem-Based Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carbapenem-Based Antibiotics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ACS Dobfar S.p.A
Iterum Therapeutics plc
DAEWOONG PHARMACEUTICAL CO.,LTD
Aurobindo Pharma Ltd
Gland Pharma Limited
Merck & Co., Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Savior Lifetec
Pfizer Inc.
Spero Therapeutics
Segment by Type
Meropenem
Doripenemu
Imipenem
Tebipenemu
Others
Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Carbapenem-Based Antibiotics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Carbapenem-Based Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Carbapenem-Based Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Carbapenem-Based Antibiotics in Retail Pharmacies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Carbapenem-Based Antibiotics include ACS Dobfar S.p.A, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL CO.,LTD, Aurobindo Pharma Ltd, Gland Pharma Limited, Merck & Co., Inc., Sumitomo Dainippon Pharma Co., Ltd., Savior Lifetec, Pfizer Inc., Spero Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Carbapenem-Based Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carbapenem-Based Antibiotics.
The Carbapenem-Based Antibiotics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Carbapenem-Based Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carbapenem-Based Antibiotics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ACS Dobfar S.p.A
Iterum Therapeutics plc
DAEWOONG PHARMACEUTICAL CO.,LTD
Aurobindo Pharma Ltd
Gland Pharma Limited
Merck & Co., Inc.
Sumitomo Dainippon Pharma Co., Ltd.
Savior Lifetec
Pfizer Inc.
Spero Therapeutics
Segment by Type
Meropenem
Doripenemu
Imipenem
Tebipenemu
Others
Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Carbapenem-Based Antibiotics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Carbapenem-Based Antibiotics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Meropenem
1.2.3 Doripenemu
1.2.4 Imipenem
1.2.5 Tebipenemu
1.2.6 Others
1.3 Market by Application
1.3.1 Global Carbapenem-Based Antibiotics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.3.4 Hospital Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Carbapenem-Based Antibiotics Market Perspective (2020-2031)
2.2 Global Carbapenem-Based Antibiotics Growth Trends by Region
2.2.1 Global Carbapenem-Based Antibiotics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Carbapenem-Based Antibiotics Historic Market Size by Region (2020-2025)
2.2.3 Carbapenem-Based Antibiotics Forecasted Market Size by Region (2026-2031)
2.3 Carbapenem-Based Antibiotics Market Dynamics
2.3.1 Carbapenem-Based Antibiotics Industry Trends
2.3.2 Carbapenem-Based Antibiotics Market Drivers
2.3.3 Carbapenem-Based Antibiotics Market Challenges
2.3.4 Carbapenem-Based Antibiotics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Carbapenem-Based Antibiotics Players by Revenue
3.1.1 Global Top Carbapenem-Based Antibiotics Players by Revenue (2020-2025)
3.1.2 Global Carbapenem-Based Antibiotics Revenue Market Share by Players (2020-2025)
3.2 Global Carbapenem-Based Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Carbapenem-Based Antibiotics Revenue
3.4 Global Carbapenem-Based Antibiotics Market Concentration Ratio
3.4.1 Global Carbapenem-Based Antibiotics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carbapenem-Based Antibiotics Revenue in 2024
3.5 Global Key Players of Carbapenem-Based Antibiotics Head office and Area Served
3.6 Global Key Players of Carbapenem-Based Antibiotics, Product and Application
3.7 Global Key Players of Carbapenem-Based Antibiotics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Carbapenem-Based Antibiotics Breakdown Data by Type
4.1 Global Carbapenem-Based Antibiotics Historic Market Size by Type (2020-2025)
4.2 Global Carbapenem-Based Antibiotics Forecasted Market Size by Type (2026-2031)
5 Carbapenem-Based Antibiotics Breakdown Data by Application
5.1 Global Carbapenem-Based Antibiotics Historic Market Size by Application (2020-2025)
5.2 Global Carbapenem-Based Antibiotics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Carbapenem-Based Antibiotics Market Size (2020-2031)
6.2 North America Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Carbapenem-Based Antibiotics Market Size by Country (2020-2025)
6.4 North America Carbapenem-Based Antibiotics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Carbapenem-Based Antibiotics Market Size (2020-2031)
7.2 Europe Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Carbapenem-Based Antibiotics Market Size by Country (2020-2025)
7.4 Europe Carbapenem-Based Antibiotics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Carbapenem-Based Antibiotics Market Size (2020-2031)
8.2 Asia-Pacific Carbapenem-Based Antibiotics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2020-2025)
8.4 Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Carbapenem-Based Antibiotics Market Size (2020-2031)
9.2 Latin America Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Carbapenem-Based Antibiotics Market Size by Country (2020-2025)
9.4 Latin America Carbapenem-Based Antibiotics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Carbapenem-Based Antibiotics Market Size (2020-2031)
10.2 Middle East & Africa Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2020-2025)
10.4 Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ACS Dobfar S.p.A
11.1.1 ACS Dobfar S.p.A Company Details
11.1.2 ACS Dobfar S.p.A Business Overview
11.1.3 ACS Dobfar S.p.A Carbapenem-Based Antibiotics Introduction
11.1.4 ACS Dobfar S.p.A Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.1.5 ACS Dobfar S.p.A Recent Development
11.2 Iterum Therapeutics plc
11.2.1 Iterum Therapeutics plc Company Details
11.2.2 Iterum Therapeutics plc Business Overview
11.2.3 Iterum Therapeutics plc Carbapenem-Based Antibiotics Introduction
11.2.4 Iterum Therapeutics plc Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.2.5 Iterum Therapeutics plc Recent Development
11.3 DAEWOONG PHARMACEUTICAL CO.,LTD
11.3.1 DAEWOONG PHARMACEUTICAL CO.,LTD Company Details
11.3.2 DAEWOONG PHARMACEUTICAL CO.,LTD Business Overview
11.3.3 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Introduction
11.3.4 DAEWOONG PHARMACEUTICAL CO.,LTD Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.3.5 DAEWOONG PHARMACEUTICAL CO.,LTD Recent Development
11.4 Aurobindo Pharma Ltd
11.4.1 Aurobindo Pharma Ltd Company Details
11.4.2 Aurobindo Pharma Ltd Business Overview
11.4.3 Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Introduction
11.4.4 Aurobindo Pharma Ltd Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.4.5 Aurobindo Pharma Ltd Recent Development
11.5 Gland Pharma Limited
11.5.1 Gland Pharma Limited Company Details
11.5.2 Gland Pharma Limited Business Overview
11.5.3 Gland Pharma Limited Carbapenem-Based Antibiotics Introduction
11.5.4 Gland Pharma Limited Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.5.5 Gland Pharma Limited Recent Development
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Details
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Carbapenem-Based Antibiotics Introduction
11.6.4 Merck & Co., Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.6.5 Merck & Co., Inc. Recent Development
11.7 Sumitomo Dainippon Pharma Co., Ltd.
11.7.1 Sumitomo Dainippon Pharma Co., Ltd. Company Details
11.7.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
11.7.3 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Introduction
11.7.4 Sumitomo Dainippon Pharma Co., Ltd. Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.7.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Development
11.8 Savior Lifetec
11.8.1 Savior Lifetec Company Details
11.8.2 Savior Lifetec Business Overview
11.8.3 Savior Lifetec Carbapenem-Based Antibiotics Introduction
11.8.4 Savior Lifetec Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.8.5 Savior Lifetec Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Carbapenem-Based Antibiotics Introduction
11.9.4 Pfizer Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.9.5 Pfizer Inc. Recent Development
11.10 Spero Therapeutics
11.10.1 Spero Therapeutics Company Details
11.10.2 Spero Therapeutics Business Overview
11.10.3 Spero Therapeutics Carbapenem-Based Antibiotics Introduction
11.10.4 Spero Therapeutics Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.10.5 Spero Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Carbapenem-Based Antibiotics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Meropenem
1.2.3 Doripenemu
1.2.4 Imipenem
1.2.5 Tebipenemu
1.2.6 Others
1.3 Market by Application
1.3.1 Global Carbapenem-Based Antibiotics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.3.4 Hospital Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Carbapenem-Based Antibiotics Market Perspective (2020-2031)
2.2 Global Carbapenem-Based Antibiotics Growth Trends by Region
2.2.1 Global Carbapenem-Based Antibiotics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Carbapenem-Based Antibiotics Historic Market Size by Region (2020-2025)
2.2.3 Carbapenem-Based Antibiotics Forecasted Market Size by Region (2026-2031)
2.3 Carbapenem-Based Antibiotics Market Dynamics
2.3.1 Carbapenem-Based Antibiotics Industry Trends
2.3.2 Carbapenem-Based Antibiotics Market Drivers
2.3.3 Carbapenem-Based Antibiotics Market Challenges
2.3.4 Carbapenem-Based Antibiotics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Carbapenem-Based Antibiotics Players by Revenue
3.1.1 Global Top Carbapenem-Based Antibiotics Players by Revenue (2020-2025)
3.1.2 Global Carbapenem-Based Antibiotics Revenue Market Share by Players (2020-2025)
3.2 Global Carbapenem-Based Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Carbapenem-Based Antibiotics Revenue
3.4 Global Carbapenem-Based Antibiotics Market Concentration Ratio
3.4.1 Global Carbapenem-Based Antibiotics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Carbapenem-Based Antibiotics Revenue in 2024
3.5 Global Key Players of Carbapenem-Based Antibiotics Head office and Area Served
3.6 Global Key Players of Carbapenem-Based Antibiotics, Product and Application
3.7 Global Key Players of Carbapenem-Based Antibiotics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Carbapenem-Based Antibiotics Breakdown Data by Type
4.1 Global Carbapenem-Based Antibiotics Historic Market Size by Type (2020-2025)
4.2 Global Carbapenem-Based Antibiotics Forecasted Market Size by Type (2026-2031)
5 Carbapenem-Based Antibiotics Breakdown Data by Application
5.1 Global Carbapenem-Based Antibiotics Historic Market Size by Application (2020-2025)
5.2 Global Carbapenem-Based Antibiotics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Carbapenem-Based Antibiotics Market Size (2020-2031)
6.2 North America Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Carbapenem-Based Antibiotics Market Size by Country (2020-2025)
6.4 North America Carbapenem-Based Antibiotics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Carbapenem-Based Antibiotics Market Size (2020-2031)
7.2 Europe Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Carbapenem-Based Antibiotics Market Size by Country (2020-2025)
7.4 Europe Carbapenem-Based Antibiotics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Carbapenem-Based Antibiotics Market Size (2020-2031)
8.2 Asia-Pacific Carbapenem-Based Antibiotics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2020-2025)
8.4 Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Carbapenem-Based Antibiotics Market Size (2020-2031)
9.2 Latin America Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Carbapenem-Based Antibiotics Market Size by Country (2020-2025)
9.4 Latin America Carbapenem-Based Antibiotics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Carbapenem-Based Antibiotics Market Size (2020-2031)
10.2 Middle East & Africa Carbapenem-Based Antibiotics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2020-2025)
10.4 Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ACS Dobfar S.p.A
11.1.1 ACS Dobfar S.p.A Company Details
11.1.2 ACS Dobfar S.p.A Business Overview
11.1.3 ACS Dobfar S.p.A Carbapenem-Based Antibiotics Introduction
11.1.4 ACS Dobfar S.p.A Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.1.5 ACS Dobfar S.p.A Recent Development
11.2 Iterum Therapeutics plc
11.2.1 Iterum Therapeutics plc Company Details
11.2.2 Iterum Therapeutics plc Business Overview
11.2.3 Iterum Therapeutics plc Carbapenem-Based Antibiotics Introduction
11.2.4 Iterum Therapeutics plc Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.2.5 Iterum Therapeutics plc Recent Development
11.3 DAEWOONG PHARMACEUTICAL CO.,LTD
11.3.1 DAEWOONG PHARMACEUTICAL CO.,LTD Company Details
11.3.2 DAEWOONG PHARMACEUTICAL CO.,LTD Business Overview
11.3.3 DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Introduction
11.3.4 DAEWOONG PHARMACEUTICAL CO.,LTD Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.3.5 DAEWOONG PHARMACEUTICAL CO.,LTD Recent Development
11.4 Aurobindo Pharma Ltd
11.4.1 Aurobindo Pharma Ltd Company Details
11.4.2 Aurobindo Pharma Ltd Business Overview
11.4.3 Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Introduction
11.4.4 Aurobindo Pharma Ltd Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.4.5 Aurobindo Pharma Ltd Recent Development
11.5 Gland Pharma Limited
11.5.1 Gland Pharma Limited Company Details
11.5.2 Gland Pharma Limited Business Overview
11.5.3 Gland Pharma Limited Carbapenem-Based Antibiotics Introduction
11.5.4 Gland Pharma Limited Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.5.5 Gland Pharma Limited Recent Development
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Details
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Carbapenem-Based Antibiotics Introduction
11.6.4 Merck & Co., Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.6.5 Merck & Co., Inc. Recent Development
11.7 Sumitomo Dainippon Pharma Co., Ltd.
11.7.1 Sumitomo Dainippon Pharma Co., Ltd. Company Details
11.7.2 Sumitomo Dainippon Pharma Co., Ltd. Business Overview
11.7.3 Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Introduction
11.7.4 Sumitomo Dainippon Pharma Co., Ltd. Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.7.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Development
11.8 Savior Lifetec
11.8.1 Savior Lifetec Company Details
11.8.2 Savior Lifetec Business Overview
11.8.3 Savior Lifetec Carbapenem-Based Antibiotics Introduction
11.8.4 Savior Lifetec Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.8.5 Savior Lifetec Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Details
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Carbapenem-Based Antibiotics Introduction
11.9.4 Pfizer Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.9.5 Pfizer Inc. Recent Development
11.10 Spero Therapeutics
11.10.1 Spero Therapeutics Company Details
11.10.2 Spero Therapeutics Business Overview
11.10.3 Spero Therapeutics Carbapenem-Based Antibiotics Introduction
11.10.4 Spero Therapeutics Revenue in Carbapenem-Based Antibiotics Business (2020-2025)
11.10.5 Spero Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Carbapenem-Based Antibiotics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Meropenem
Table 3. Key Players of Doripenemu
Table 4. Key Players of Imipenem
Table 5. Key Players of Tebipenemu
Table 6. Key Players of Others
Table 7. Global Carbapenem-Based Antibiotics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Carbapenem-Based Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Carbapenem-Based Antibiotics Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Carbapenem-Based Antibiotics Market Share by Region (2020-2025)
Table 11. Global Carbapenem-Based Antibiotics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Carbapenem-Based Antibiotics Market Share by Region (2026-2031)
Table 13. Carbapenem-Based Antibiotics Market Trends
Table 14. Carbapenem-Based Antibiotics Market Drivers
Table 15. Carbapenem-Based Antibiotics Market Challenges
Table 16. Carbapenem-Based Antibiotics Market Restraints
Table 17. Global Carbapenem-Based Antibiotics Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Carbapenem-Based Antibiotics Market Share by Players (2020-2025)
Table 19. Global Top Carbapenem-Based Antibiotics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem-Based Antibiotics as of 2024)
Table 20. Ranking of Global Top Carbapenem-Based Antibiotics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Carbapenem-Based Antibiotics Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Carbapenem-Based Antibiotics, Headquarters and Area Served
Table 23. Global Key Players of Carbapenem-Based Antibiotics, Product and Application
Table 24. Global Key Players of Carbapenem-Based Antibiotics, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Carbapenem-Based Antibiotics Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Carbapenem-Based Antibiotics Revenue Market Share by Type (2020-2025)
Table 28. Global Carbapenem-Based Antibiotics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Carbapenem-Based Antibiotics Revenue Market Share by Type (2026-2031)
Table 30. Global Carbapenem-Based Antibiotics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Carbapenem-Based Antibiotics Revenue Market Share by Application (2020-2025)
Table 32. Global Carbapenem-Based Antibiotics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Carbapenem-Based Antibiotics Revenue Market Share by Application (2026-2031)
Table 34. North America Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Carbapenem-Based Antibiotics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)
Table 49. ACS Dobfar S.p.A Company Details
Table 50. ACS Dobfar S.p.A Business Overview
Table 51. ACS Dobfar S.p.A Carbapenem-Based Antibiotics Product
Table 52. ACS Dobfar S.p.A Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 53. ACS Dobfar S.p.A Recent Development
Table 54. Iterum Therapeutics plc Company Details
Table 55. Iterum Therapeutics plc Business Overview
Table 56. Iterum Therapeutics plc Carbapenem-Based Antibiotics Product
Table 57. Iterum Therapeutics plc Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 58. Iterum Therapeutics plc Recent Development
Table 59. DAEWOONG PHARMACEUTICAL CO.,LTD Company Details
Table 60. DAEWOONG PHARMACEUTICAL CO.,LTD Business Overview
Table 61. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Product
Table 62. DAEWOONG PHARMACEUTICAL CO.,LTD Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 63. DAEWOONG PHARMACEUTICAL CO.,LTD Recent Development
Table 64. Aurobindo Pharma Ltd Company Details
Table 65. Aurobindo Pharma Ltd Business Overview
Table 66. Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Product
Table 67. Aurobindo Pharma Ltd Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 68. Aurobindo Pharma Ltd Recent Development
Table 69. Gland Pharma Limited Company Details
Table 70. Gland Pharma Limited Business Overview
Table 71. Gland Pharma Limited Carbapenem-Based Antibiotics Product
Table 72. Gland Pharma Limited Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 73. Gland Pharma Limited Recent Development
Table 74. Merck & Co., Inc. Company Details
Table 75. Merck & Co., Inc. Business Overview
Table 76. Merck & Co., Inc. Carbapenem-Based Antibiotics Product
Table 77. Merck & Co., Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 78. Merck & Co., Inc. Recent Development
Table 79. Sumitomo Dainippon Pharma Co., Ltd. Company Details
Table 80. Sumitomo Dainippon Pharma Co., Ltd. Business Overview
Table 81. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Product
Table 82. Sumitomo Dainippon Pharma Co., Ltd. Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 83. Sumitomo Dainippon Pharma Co., Ltd. Recent Development
Table 84. Savior Lifetec Company Details
Table 85. Savior Lifetec Business Overview
Table 86. Savior Lifetec Carbapenem-Based Antibiotics Product
Table 87. Savior Lifetec Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 88. Savior Lifetec Recent Development
Table 89. Pfizer Inc. Company Details
Table 90. Pfizer Inc. Business Overview
Table 91. Pfizer Inc. Carbapenem-Based Antibiotics Product
Table 92. Pfizer Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 93. Pfizer Inc. Recent Development
Table 94. Spero Therapeutics Company Details
Table 95. Spero Therapeutics Business Overview
Table 96. Spero Therapeutics Carbapenem-Based Antibiotics Product
Table 97. Spero Therapeutics Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 98. Spero Therapeutics Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. Authors List of This Report
List of Figures
Figure 1. Carbapenem-Based Antibiotics Picture
Figure 2. Global Carbapenem-Based Antibiotics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Carbapenem-Based Antibiotics Market Share by Type: 2024 VS 2031
Figure 4. Meropenem Features
Figure 5. Doripenemu Features
Figure 6. Imipenem Features
Figure 7. Tebipenemu Features
Figure 8. Others Features
Figure 9. Global Carbapenem-Based Antibiotics Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Carbapenem-Based Antibiotics Market Share by Application: 2024 VS 2031
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Hospital Pharmacies Case Studies
Figure 14. Carbapenem-Based Antibiotics Report Years Considered
Figure 15. Global Carbapenem-Based Antibiotics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Carbapenem-Based Antibiotics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Carbapenem-Based Antibiotics Market Share by Region: 2024 VS 2031
Figure 18. Global Carbapenem-Based Antibiotics Market Share by Players in 2024
Figure 19. Global Top Carbapenem-Based Antibiotics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem-Based Antibiotics as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Carbapenem-Based Antibiotics Revenue in 2024
Figure 21. North America Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Carbapenem-Based Antibiotics Market Share by Country (2020-2031)
Figure 23. United States Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Carbapenem-Based Antibiotics Market Share by Country (2020-2031)
Figure 27. Germany Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Carbapenem-Based Antibiotics Market Share by Region (2020-2031)
Figure 35. China Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Carbapenem-Based Antibiotics Market Share by Country (2020-2031)
Figure 43. Mexico Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Carbapenem-Based Antibiotics Market Share by Country (2020-2031)
Figure 47. Turkey Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. ACS Dobfar S.p.A Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 51. Iterum Therapeutics plc Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 52. DAEWOONG PHARMACEUTICAL CO.,LTD Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 53. Aurobindo Pharma Ltd Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 54. Gland Pharma Limited Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 55. Merck & Co., Inc. Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 56. Sumitomo Dainippon Pharma Co., Ltd. Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 57. Savior Lifetec Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 58. Pfizer Inc. Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 59. Spero Therapeutics Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Carbapenem-Based Antibiotics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Meropenem
Table 3. Key Players of Doripenemu
Table 4. Key Players of Imipenem
Table 5. Key Players of Tebipenemu
Table 6. Key Players of Others
Table 7. Global Carbapenem-Based Antibiotics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Carbapenem-Based Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Carbapenem-Based Antibiotics Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Carbapenem-Based Antibiotics Market Share by Region (2020-2025)
Table 11. Global Carbapenem-Based Antibiotics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Carbapenem-Based Antibiotics Market Share by Region (2026-2031)
Table 13. Carbapenem-Based Antibiotics Market Trends
Table 14. Carbapenem-Based Antibiotics Market Drivers
Table 15. Carbapenem-Based Antibiotics Market Challenges
Table 16. Carbapenem-Based Antibiotics Market Restraints
Table 17. Global Carbapenem-Based Antibiotics Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Carbapenem-Based Antibiotics Market Share by Players (2020-2025)
Table 19. Global Top Carbapenem-Based Antibiotics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem-Based Antibiotics as of 2024)
Table 20. Ranking of Global Top Carbapenem-Based Antibiotics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Carbapenem-Based Antibiotics Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Carbapenem-Based Antibiotics, Headquarters and Area Served
Table 23. Global Key Players of Carbapenem-Based Antibiotics, Product and Application
Table 24. Global Key Players of Carbapenem-Based Antibiotics, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Carbapenem-Based Antibiotics Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Carbapenem-Based Antibiotics Revenue Market Share by Type (2020-2025)
Table 28. Global Carbapenem-Based Antibiotics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Carbapenem-Based Antibiotics Revenue Market Share by Type (2026-2031)
Table 30. Global Carbapenem-Based Antibiotics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Carbapenem-Based Antibiotics Revenue Market Share by Application (2020-2025)
Table 32. Global Carbapenem-Based Antibiotics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Carbapenem-Based Antibiotics Revenue Market Share by Application (2026-2031)
Table 34. North America Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Carbapenem-Based Antibiotics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Carbapenem-Based Antibiotics Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Carbapenem-Based Antibiotics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Carbapenem-Based Antibiotics Market Size by Country (2026-2031) & (US$ Million)
Table 49. ACS Dobfar S.p.A Company Details
Table 50. ACS Dobfar S.p.A Business Overview
Table 51. ACS Dobfar S.p.A Carbapenem-Based Antibiotics Product
Table 52. ACS Dobfar S.p.A Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 53. ACS Dobfar S.p.A Recent Development
Table 54. Iterum Therapeutics plc Company Details
Table 55. Iterum Therapeutics plc Business Overview
Table 56. Iterum Therapeutics plc Carbapenem-Based Antibiotics Product
Table 57. Iterum Therapeutics plc Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 58. Iterum Therapeutics plc Recent Development
Table 59. DAEWOONG PHARMACEUTICAL CO.,LTD Company Details
Table 60. DAEWOONG PHARMACEUTICAL CO.,LTD Business Overview
Table 61. DAEWOONG PHARMACEUTICAL CO.,LTD Carbapenem-Based Antibiotics Product
Table 62. DAEWOONG PHARMACEUTICAL CO.,LTD Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 63. DAEWOONG PHARMACEUTICAL CO.,LTD Recent Development
Table 64. Aurobindo Pharma Ltd Company Details
Table 65. Aurobindo Pharma Ltd Business Overview
Table 66. Aurobindo Pharma Ltd Carbapenem-Based Antibiotics Product
Table 67. Aurobindo Pharma Ltd Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 68. Aurobindo Pharma Ltd Recent Development
Table 69. Gland Pharma Limited Company Details
Table 70. Gland Pharma Limited Business Overview
Table 71. Gland Pharma Limited Carbapenem-Based Antibiotics Product
Table 72. Gland Pharma Limited Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 73. Gland Pharma Limited Recent Development
Table 74. Merck & Co., Inc. Company Details
Table 75. Merck & Co., Inc. Business Overview
Table 76. Merck & Co., Inc. Carbapenem-Based Antibiotics Product
Table 77. Merck & Co., Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 78. Merck & Co., Inc. Recent Development
Table 79. Sumitomo Dainippon Pharma Co., Ltd. Company Details
Table 80. Sumitomo Dainippon Pharma Co., Ltd. Business Overview
Table 81. Sumitomo Dainippon Pharma Co., Ltd. Carbapenem-Based Antibiotics Product
Table 82. Sumitomo Dainippon Pharma Co., Ltd. Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 83. Sumitomo Dainippon Pharma Co., Ltd. Recent Development
Table 84. Savior Lifetec Company Details
Table 85. Savior Lifetec Business Overview
Table 86. Savior Lifetec Carbapenem-Based Antibiotics Product
Table 87. Savior Lifetec Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 88. Savior Lifetec Recent Development
Table 89. Pfizer Inc. Company Details
Table 90. Pfizer Inc. Business Overview
Table 91. Pfizer Inc. Carbapenem-Based Antibiotics Product
Table 92. Pfizer Inc. Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 93. Pfizer Inc. Recent Development
Table 94. Spero Therapeutics Company Details
Table 95. Spero Therapeutics Business Overview
Table 96. Spero Therapeutics Carbapenem-Based Antibiotics Product
Table 97. Spero Therapeutics Revenue in Carbapenem-Based Antibiotics Business (2020-2025) & (US$ Million)
Table 98. Spero Therapeutics Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. Authors List of This Report
List of Figures
Figure 1. Carbapenem-Based Antibiotics Picture
Figure 2. Global Carbapenem-Based Antibiotics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Carbapenem-Based Antibiotics Market Share by Type: 2024 VS 2031
Figure 4. Meropenem Features
Figure 5. Doripenemu Features
Figure 6. Imipenem Features
Figure 7. Tebipenemu Features
Figure 8. Others Features
Figure 9. Global Carbapenem-Based Antibiotics Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Carbapenem-Based Antibiotics Market Share by Application: 2024 VS 2031
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Hospital Pharmacies Case Studies
Figure 14. Carbapenem-Based Antibiotics Report Years Considered
Figure 15. Global Carbapenem-Based Antibiotics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Carbapenem-Based Antibiotics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Carbapenem-Based Antibiotics Market Share by Region: 2024 VS 2031
Figure 18. Global Carbapenem-Based Antibiotics Market Share by Players in 2024
Figure 19. Global Top Carbapenem-Based Antibiotics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carbapenem-Based Antibiotics as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Carbapenem-Based Antibiotics Revenue in 2024
Figure 21. North America Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Carbapenem-Based Antibiotics Market Share by Country (2020-2031)
Figure 23. United States Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Carbapenem-Based Antibiotics Market Share by Country (2020-2031)
Figure 27. Germany Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Carbapenem-Based Antibiotics Market Share by Region (2020-2031)
Figure 35. China Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Carbapenem-Based Antibiotics Market Share by Country (2020-2031)
Figure 43. Mexico Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Carbapenem-Based Antibiotics Market Share by Country (2020-2031)
Figure 47. Turkey Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Carbapenem-Based Antibiotics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. ACS Dobfar S.p.A Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 51. Iterum Therapeutics plc Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 52. DAEWOONG PHARMACEUTICAL CO.,LTD Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 53. Aurobindo Pharma Ltd Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 54. Gland Pharma Limited Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 55. Merck & Co., Inc. Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 56. Sumitomo Dainippon Pharma Co., Ltd. Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 57. Savior Lifetec Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 58. Pfizer Inc. Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 59. Spero Therapeutics Revenue Growth Rate in Carbapenem-Based Antibiotics Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232